Dr. Nirav S. Patel, MD

Dr. Patel practices at Southland Neurologic Institute a Medical Corporation in Long Beach, California.

Dr. Patel's NPI, 1881631539, was assigned on June 1, 2006. Dr. Patel graduated from David Geffen School of Medicine at UCLA in 1992. Dr. Patel holds California license G79448.

Dr. Patel's primary practice is Southland Neurologic Institute a Medical Corporation, at 3747 Worsham Ave, Long Beach, CA 90808 in Los Angeles County. The practice phone is (562) 430-4513.

Dr. Patel's primary practice is Southland Neurologic Institute a Medical Corporation in Long Beach, California. Dr. Patel is also affiliated with Long Beach Medical Center. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Patel to 3 more hospitals, 2 group practices and clinics, 2 medical groups, 1 physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Patel is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Patel is licensed in California.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, fibromyalgia and chronic pain, head injury and hereditary polyneuropathy among the conditions Dr. Patel treats.

CMS data shows 153,726 Medicare services from Dr. Patel across 15 procedure codes in 2024, for 700 Medicare patients. Medicare paid $416,436 for them.

CMS counts 700 Medicare patients who saw Dr. Patel in 2024. The largest group is 75 to 84, with 261 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 70, with 59% women.

In 2024, Dr. Patel wrote 1,576 Medicare Part D claims for 200 patients. 84% of them were for generic drugs. CMS names the drug for 1,236 of them, across 50 drugs with 11 or more claims each, at $544,060 in total drug cost. In 2023, CMS named 1,100 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Patel for performance year 2024, reported individually. Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Patel as offering telehealth.

Dmand AI links Dr. Patel to 2 clinical trials. Conditions studied include Hyperalgesia, Vitamin B Deficiency and Avitaminosis. Open Payments lists research payments to Dr. Patel that name 1 trial.

CMS Open Payments shows 1,894 general payments to Dr. Patel from 74 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. AstraZeneca Pharmaceuticals LP paid the most, $280,823. It also lists 19 research payments totaling $52,941 from 2016 to 2023, naming 1 clinical trial.

Dmand AI lists 3 awards for Dr. Patel, most recently Top Doctors:Southern California in 2015. Dr. Patel serves on Peer Review Committee- Los Alamitos Medical Center.

Dr. Patel graduated from David Geffen School of Medicine at UCLA in 1992. Dr. Patel is a member of AAN and AHA.

Dr. Patel is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.